BRGXOTCServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
BIOREGENX, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $3.88M
- P/E (TTM)
- –
- Dividend yield
- –
BIOREGENX, INC. revenue by segment
By business segment
By product or service
| Revenue | TTM Q4 25 | TTM Q4 24 | % of revenue | YoY |
|---|---|---|---|---|
| Nutritional [Member] | $1.63M | $1.82M | 87.8% | -10.8% |
| Medical Testing [Member] | $207.93K | $587.62K | 11.2% | -64.6% |
| Wellness Devices [Member] | $25.42K | $186.30K | 1.4% | -86.4% |
| Other Sales [Member] | $884 | – | 0.0% | – |
By region
From the segment and revenue-disaggregation notes of Bioregenx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.